Biogen Idec’s TECFIDERA™ approved in US as a first-line oral treatment for multiple sclerosis
The U.S. FDA has approved TECFIDERA™...
27 March 2013 | By Biogen Idec
The U.S. FDA has approved TECFIDERA™...
List view / Grid view
The U.S. FDA has approved TECFIDERA™...
27 March 2013 | By Biogen Idec
The U.S. FDA has approved TECFIDERA™...
AUBAGIO® (teriflunomide), a once-daily, oral treatment for relapsing Multiple Sclerosis...
12 September 2012 | By Sanofi
AUBAGIO® (teriflunomide), a once-daily, oral treatment for relapsing Multiple Sclerosis...